Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cranial Bio is a neurotechnology and biotechnology company focused on developing advanced interfaces for the human brain to treat complex neurological conditions. The company is building a platform designed to provide chronic, high-bandwidth access to the brain, enabling the delivery of precision therapeutics and real-time monitoring of neural health. By combining neurosurgery, engineering, and biology, Cranial Bio aims to transform the treatment landscape for indications such as brain tumors and neurodegenerative diseases. Their approach centers on creating a permanent, safe portal for direct brain intervention without the need for repeated invasive surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cranial Biotech.